How Well Does a New Medication Work for Severe Bowel Inflammation in Japan

This study is following about 200 Japanese patients who have been prescribed risankizumab by their doctor for moderate to severe ulcerative colitis — a condition that causes inflammation and bleeding in the colon and rectum. Researchers want to understand how well this medication reduces disease activity and improves quality of life in real-world clinical practice. You would simply continue taking the medication exactly as your doctor prescribes it, with regular follow-up visits as part of your normal care.

Ulcerative colitis can be very difficult to manage and significantly impacts daily life. This study exists to see how effective this medication is at reducing symptoms and improving the lives of patients in Japan who are already using it as part of their standard treatment.